Chester County News and Community Website
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the presentation of its investigational therapy QTORIN™ rapamycin 3.9% anhydrous gel for microcystic lymphatic malformations (microcystic LMs) at the 15th World …
Palvella Therapeutics Showcases Progress on QTORIN Rapamycin Gel for Rare Genetic Disorder Read More
WASHINGTON, D.C. — U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. and U.S. Secretary of Agriculture Brooke L. Rollins joined forces on Thursday to kick off the …
How HHS and USDA Plan to Tackle Childhood Obesity with Bold New Initiative Read More
PHILADELPHIA, PA — A recent study conducted across nine Iowa hospitals has shown promising results in reducing postoperative opioid prescriptions by implementing Enhanced Recovery After Surgery (ERAS) pathways.
Enhanced Recovery Pathways Slash Opioid Prescriptions Read More
EXTON, PA — The Chester County Economic Development Council (CCEDC) is set to host the Coatesville Community Health & Wellness Fair on Sunday, April 13, from 12 p.m. to 4 …
Join the Coatesville Community for a Free Day of Health, Fun, and Connection on April 13! Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced that its AC3 Range™ Intra-Aortic Balloon Pump (IABP) has received FDA 510(k) clearance. Designed for seamless intra-aortic balloon pumping across various modes …
Teleflex Secures FDA Clearance for AC3 Range IABP, Enhancing Cardiac Patient Transport Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) revealed a significant development in mental healthcare, announcing that Evernorth Health Services, a subsidiary of The Cigna Group, has expanded its coverage of NeuroStar® …
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression Read More
WILMINGTON, DE — AstraZeneca presented new data on TAGRISSO® (osimertinib) at the European Lung Cancer Congress (ELCC) 2025, reinforcing its role as a backbone therapy across treatment stages for epidermal growth …
AstraZeneca Showcases TAGRISSO’s Potential in EGFR-Mutated Lung Cancer at ELCC 2025 Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced the approval of Qfitlia (fitusiran), a treatment designed to prevent or reduce the frequency of bleeding episodes in …
FDA Approves Qfitlia: A Breakthrough Treatment Revolutionizing Hemophilia Care Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has released a series of announcements covering a wide range of initiatives and regulatory updates, reflecting the agency’s ongoing commitment …
FDA Unveils Key Updates on Rare Disease Advances, Food Safety, and Medical Innovations Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has granted Visby Medical marketing authorization for its Women’s Sexual Health Test, a groundbreaking diagnostic tool that allows at-home testing …
Revolution in Healthcare: FDA Greenlights First At-Home Test for Three Major STIs Read More